Oshimura M, Shimizu M, Kugoh H
Department of Molecular and Cell Genetics, School of Life Sciences, Faculty of Medicine, Tottori University.
Hum Cell. 1996 Dec;9(4):301-8.
Hybrids between immortal cells and normal cells senesce, indicating that immortal cells have lost, mutated or inactivated genes that are required for the program of senescence in normal cells. Genes involved in the senescence program have been mapped to over 10 different genetic loci by introduction of normal human chromosomes via microcell fusion. Multiple pathways of cellular senescence have also been demonstrated by chromosome transfer, indicating that the functions of the mapped senescence genes are probably different. One possibility is that one or more of these senescence genes may suppress telomerase activity in immortal cells, resulting in telomere shortening and cellular senescence. To test this hypothesis, telomerase activity and the length of terminal restriction fragments (TRFs) have been examined in microcell hybrids. The loss of indefinite growth potential was either with or without the loss of telomerase activity activity and shortening of telomeres in the microcell hybrids containing the introduced chromosome. The findings suggest that telomerase regulation is one of multiple pathways to cellular senescence.
永生细胞与正常细胞之间的杂交细胞会衰老,这表明永生细胞已经丢失、突变或使正常细胞衰老程序所需的基因失活。通过微细胞融合引入正常人染色体,已将参与衰老程序的基因定位到10多个不同的基因位点。通过染色体转移也证明了细胞衰老的多种途径,这表明定位的衰老基因的功能可能不同。一种可能性是,这些衰老基因中的一个或多个可能抑制永生细胞中的端粒酶活性,导致端粒缩短和细胞衰老。为了验证这一假设,已在微细胞杂交体中检测了端粒酶活性和末端限制片段(TRF)的长度。在含有导入染色体的微细胞杂交体中,无限生长潜能的丧失与端粒酶活性的丧失和端粒缩短与否有关。这些发现表明,端粒酶调控是细胞衰老的多种途径之一。